Aidmedsp. z o.o.

Data processing, hosting and related activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2018-03-06
Share capital
7 150,00 PLN
Activity description

Aidmed is a company that develops an AI-based system for measuring patient vital signs, including a portable device called Aidmed One and a finger pulse oximeter (BM2000D). The system collects various biosignals such as bioimpedance, accelerometry, and SpO2 levels, and transmits data to a mobile application (Aidmed Health) for patient monitoring. Additionally, Aidmed offers a telemedicine platform for managing studies related to sleep apnea, ECG holters, and monitoring patients with COVID-19 symptoms.

Registered address
ul. Oliwska 85, 80-542 Gdańsk, Poland
Website
aidmed.aiWebsite active
Email
Email warning
Phone
Social media
Electronic delivery address
AE:PL-32935-42415-FTJHT-32

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 263.70kMedianUSD 51.79kAverageUSD 1.99m
Net profit
This companyUSD 84.34kMedianUSD 743.75AverageUSD 103.69k
Operating costs
This companyUSD 179.36kMedianUSD 52.35kAverageUSD 1.79m
Assets
This companyUSD 114.09kMedianUSD 45.68kAverageUSD 2.43m

Bank accounts

Registered as a VAT taxpayer on 2019-03-01. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

9 public aid cases recorded, with a total value of $1,142,886.

Grant datePurposeGross amountGranting body
Mar 25, 2021
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$69,316Prezes Polskiej Agencji Rozwoju Przedsiębiorczości
Oct 9, 2020
Aid for SME access to finance — aid for start-ups
$215,396Dyrektor Narodowego Centrum Badań i Rozwoju
Sep 22, 2020
Aid for research and development projects: industrial research
$730,655Dyrektor Narodowego Centrum Badań i Rozwoju

European Funds

StartProjectEU co-financingProgramme
2021-01-01
Opracowanie technologii pozwalających na wykorzystanie sensora biosygnałów do ulepszenia interakcji użytkownika ze światem gry.
$858,400Program Operacyjny Inteligentny Rozwój
2020-09-01
Przygotowanie projektu o Eurogrant planowanego do realizacji w ramach programu EIC Accelerator
$71,814Program Operacyjny Inteligentny Rozwój

Tenders

2 tenders recorded as contractor: 1 national ($16,824) and 1 EU ($309,141).

Publication dateSubjectAmountContracting authority
Nov 17, 2025
72.2025 Dostawa oprogramowania serwerowego oraz aplikacji mobilnej wraz ze szkoleniem z systemu teleinformatycznego oraz dostawą sprzętu do monitorowania rehabilitacji w domu – Projekt pn. "Ocena wpływu telerehabilitacji krążeniowo-oddechowej na sprawność ogólną i jakość życia pacjentów z tętniczym nadciśnieniem płucnym"
$309,141Uniwersytet Medyczny Im. Piastów Śląskich we Wrocławiu
Mar 7, 2022
Zakup wraz z dostawą i szkoleniem nowej aparatury dydaktycznej do laboratorium dydaktycznego Wydziału Nauk Społecznych UWM w Olsztynie w ramach projektu nr POWR.03.05.00-00-Z310/17
$16,824Uniwersytet Warmińsko – Mazurski w Olsztynie

Regulatory authorisations

AuthorityTypeStatus
BDO
BDO register entry Active

Authorized Representatives

Jakub Łukasz Domaszewicz — Management Board Member

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
Łukasz Jan Czekaj (44)
12$162.078.3916%
Jakub Łukasz Domaszewicz (37)
53$715.8337.0629%
Inven Sp. z o.o.
53$715.8337.0629%
Life Science Innovations Sp. z o.o. Sp. K.
25$337.6617.4825%

Beneficial owners

PersonRights
Jakub Łukasz Domaszewicz (37)
Shareholder of a limited liability company, 2250.0 PLN
Marta Kitłowska (52)
Posiadanie 68.35% udziałów w inven sp. z o.o. będącej właścicielem 45 (31%) udziałów o wart. 2250zł zgłaszanej spółki: aidmed sp. z o.o.

Competitors

NameRevenueWebsite
Edoktor24 InternationalS.A.$619,437.67edoktor24.pl
Ea24sp. z o.o.$364,192.38ea24.pl
Egabinetsp. z o.o.$361,329.99egabinet.pl
IT Medico-Serwsp. z o.o.$172,032.86it-medicoserw.pl
Medycy24sp. z o.o.$89,256.58medycy24.pl
Upmedicsp. z o.o.$87,477.63upmedic.io

Change history

DateEvent
2024-12-06Address change (Ul. Partyzantów 76, 80-254, Gdańsk → Ul. Oliwska 85, 80-542, Gdańsk)
2023-11-06Address change (Ul. Jaśkowa Dolina 75/16, 80-286, Gdańsk → Ul. Partyzantów 76, 80-254, Gdańsk)
2023-02-07Address change (Ul. Jana Uphagena 27, 80-237, Gdańsk → Ul. Jaśkowa Dolina 75/16, 80-286, Gdańsk)
2022-04-11Address change (Ul. Jana Uphagena 27/702, 80-237, Gdańsk → Ul. Jana Uphagena 27, 80-237, Gdańsk)
2021-01-27Share capital change (5,000.00 PLN → 7,150.00 PLN)

FAQ

Last updated: 2026-07-30